Blog

Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background

PulmonIR

PulmonIR is a Swansea-based, early-stage medical device company focused on the detection and monitoring of lung diseases, including Chronic Obstructive Pulmonary Disease (COPD). PulmonIR’s proprietary technology is based on the work of Professor Paul Lewis at Swansea University. Having secured a significant venture capital investment from IP Group, the Development Bank of Wales and the Swansea University Innovation Fund, this technology is currently undergoing clinical evaluation through a collaboration involving Cwm Taf University Health Board. Following completion of these clinical trials, PulmonIR will seek the necessary regulatory approvals before launching its commercial products into the UK National Health Service and international healthcare markets.